About: http://webisa.webdatacommons.org/66192769

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	This press release may contain forward-looking statements, including statements that Vertex plans to initiate clinical studies of VX-950 in the stated timeframe.
http://www.w3.org/ns/prov#wasQuotedFrom	natap.org